An observational study in Respiratory Failure, Hypoxemia and Hyperoxemia, sponsored by Laval University. Recruiting at 5 sites in 3 countries. Open to participants aged 0 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Laval University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 94 studies in Respiratory Insufficiency with a site in Canada — 24 open to participants now, 29 under way, 1 of them phase 3. Respiratory Insufficiency · Canada.
Among the 94 studies in Respiratory Insufficiency with a site in Canada, this one is the 8th largest by planned enrollment of the 28 observational ones that give a count, is one of 7 that started in 2024, is one of 28 observational ones, reaches primary completion later than 21 of the 28 other live ones, and was the 82nd registered.
1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.
Browse Respiratory Insufficiency studies →24 of the 94 studies in Respiratory Insufficiency with a site in Canada are open now. Recruiting first, the newest first:
University Health Network, Toronto · Sites in Canada
Ages 18+
University of Alberta · Sites in Canada
Ages 18+
Laval University · Sites in Canada
Ages 18+
Lorenzo delSorbo · Sites in Canada
Ages 18+
Laval University · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.
This study: 0 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
94 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 7 · Phase 3 12 · Phase 4 1
First in 1995; this study’s year is marked. 7 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 250 is above the median of 100 across 456 observational studies indexed under Respiratory Insufficiency.
Median enrollment 31 across the 66 interventional studies, 118 across the 28 observational. Of the 54 that completed or were terminated, 5 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 94 have an industry lead sponsor. The 10 most frequent:
Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.
Laval University has 8 studies filed under Respiratory Insufficiency — fewer than ten, so there is no comparison to draw.
11 of the studies in Respiratory Insufficiency with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07518862University Health Network, TorontoHeart Rate VAriability as a MaRker for tItrATing hIgh flOw Nasal Cannula Therapy | 2026-11 |
| NCT04524585University Health Network, TorontoPartial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure | 2026-12-01 |
| NCT07359261University of AlbertaTranspulmonary Assessment for Individualized Lung Optimization in Obese Patients | 2026-12-31 |
| NCT07334379Lorenzo delSorboInterleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study | 2027-02-20 |
| NCT05440851University Health Network, TorontoPlatform of Randomized Adaptive Clinical Trials in Critical Illness | 2027-03-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 94 studies in Respiratory Insufficiency with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The oximeter is used to monitor intensive care patients undergoing oxygen therapy. It indicates pulsed oxygen saturation (SpO2), a reflection of arterial oxygen saturation (SaO2) which enables detection of hypoxemia and hyperoxia, both deleterious state. Current SpO2 recommendations aim to reduce both risk of hypoxemia and hyperoxia. SpO2 is considered the 5th vital sign.
Current recommendations for SpO2 targets do not consider the variability of oximeters used in clinical practice. This variability and lack of specification represent an obstacle to an optimal practice of oxygen therapy.
Thus, this study aims to compare the SpO2 values of different oximeters (General Electric-GE, Medtronic, Masimo and Nonin) used in clinical practice with the SaO2 reference value obtained by an arterial gas in order to specify the precision and the systematic biases of the oximeters studied. This data will also make it possible to refine the recommendations concerning optimal oxygenation
All patient in ICU with arterial catheter already installed will be consider
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adult population
Inclusion Criteria:
Pediatric population
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Pediatric population \< 18 years old (estimated 100 patients)
Device: SpO2 and SaO2 comparison
Adult population \>or= 18 years old (estimated 150 patients)
Device: SpO2 and SaO2 comparison
Several pulse oximeter will be place on patient find few minutes before arterial blood gases. During an arterial blood sample, all SpO2 will be recorded
Difference between GE oximeter SpO2 value and the SaO2 value on arterial blood gases
Difference between GE oximeter SpO2 and the SaO2 value
Time frame: During procedure (arterial blood gas sample collection)
Difference between Nellcor oximeter SpO2 value and the SaO2 value on arterial blood gases
Difference between Nellcor oximeter SpO2 and the SaO2 value
Time frame: During procedure (arterial blood gassample collection)
Difference between Masimo oximeter SpO2 value and the SaO2 value on arterial blood gases
Difference between Masimo oximeter SpO2 and the SaO2 value
Time frame: During procedure (arterial blood gas sample collection)
Difference between Nonin oximeter SpO2 value and the SaO2 value on arterial blood gases
Difference between Nonin oximeter SpO2 and the SaO2 value
Time frame: During procedure (arterial blood gas sample collection)
Overestimation and underestimation of SaO2
Percent of pairs with overestimation and underestimation of SaO2 for each oximeter.
Time frame: During procedure (arterial blood gas sample collection)
Hypoxemia detection
Ability to detect hypoxemia (SpO2 below 90% and PaO2 \< 60 mmHg)
Time frame: During procedure (arterial blood gas sample collection)
Hyperoxemia detection
Ability to detect hyperoxemia (SpO2 above 95% and PaO2 \> 100 mmHg)
Time frame: During procedure (arterial blood gas sample collection)
Gaps between the different oximeters
Average of the SpO2 value gaps between the different oximeters tested
Time frame: During procedure (arterial blood gas sample collection)
Not enrolling at this site.
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2024 (actual). Primary completion is estimated for Jun 2027, 36 months after the start.
Of 232 non-industry observational studies under Respiratory Insufficiency, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's planned 36 months is above that.
Counting every sponsor, half of 248 studies reached it within 22 months; a quarter within 12 and three quarters within 44.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Jun 2026 → Jun 2027 and completion Dec 2026 → Dec 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.